Stock listing

Ani Pharmaceuticals, Inc.

Selected listing: A1W15D · LS · EUR · DE

Ani Pharmaceuticals, Inc. (Lang & Schwarz: A1W15D), Health Technology. Latest release Sep 30, 2026: ANI Pharmaceuticals Announces New Fluocinolone Acetonide…

A1W15D:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A1W15D
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Ani Pharmaceuticals, Inc.

ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting

September 29, 2026

ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting

September 30, 2026

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension

September 23, 2026

ANI Pharmaceuticals to Present at September Investor Conferences

September 3, 2026

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors

August 24, 2026

All Ani Pharmaceuticals, Inc. news →

Events

Replays

ANI Pharmaceuticals, Inc. (ANIP) Q2 2026 Earnings Call
Fri, Aug 07, 2026 · 08:00 AM ET
Watch
ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call
Fri, May 08, 2026 · 08:00 AM ET
Watch
ANI Pharmaceuticals, Inc. (ANIP) Q4 2025 Earnings Call
Fri, Feb 27, 2026 · 08:00 AM ET
Watch

Research Ani Pharmaceuticals, Inc.

Ani Pharmaceuticals, Inc. company profile

View the public company page for Ani Pharmaceuticals, Inc. on 6ix.

Ani Pharmaceuticals, Inc. news

Read company news and market updates connected to Ani Pharmaceuticals, Inc..

Ani Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Ani Pharmaceuticals, Inc..